The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.

Cody RaminGretchen L GierachMustapha AbubakarLene H S VeigaJacqueline B VoRochelle E CurtisErin J Aiello BowlesHeather Spencer FeigelsonDiana S M BuistAmy Berrington de GonzalezClara Bodelon

Published in: Cancer causes & control : CCC (2022)

Our findings suggest that ER + /PR- tumors may have worse breast cancer-specific mortality than ER + /PR + tumors in a community setting.

Keyphrases

healthcare
cardiovascular events
estrogen receptor
endoplasmic reticulum
risk factors
breast cancer cells
type diabetes
cardiovascular disease
combination therapy
breast cancer risk
young adults
social media
replacement therapy
health information
childhood cancer